{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-047904","form_type":"8-K","ticker":"VYGR","cik":"0001640266","company_name":"Voyager Therapeutics, Inc.","filed_at":"2022-04-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.589618+00:00","generated_at":"2026-06-26T06:11:55.388638+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Two Voyager directors request not to be renominated; search for replacements underway","bullets":["Mark Levin and Steven Paul, M.D. will not stand for re-election at 2022 annual meeting.","Both directors cited desire to reduce professional commitments and board seats.","Departures not due to any disagreement with board or management.","Nominating committee has engaged search firm to fill anticipated vacancies."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-047904","json":"https://secwatch.observer/filing/0001104659-22-047904.json","markdown":"https://secwatch.observer/filing/0001104659-22-047904.md","text":"https://secwatch.observer/filing/0001104659-22-047904.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1640266/000110465922047904/0001104659-22-047904-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1640266/000110465922047904/tm2213132d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T06:11:55.388638+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1fe91d6b58","claim":"Steven Paul, M.D. departed as Director at Voyager Therapeutics, Inc..","evidence_excerpt":"Mark Levin and Steven Paul, M.D. each requested not to be nominated for re-election to the Board when his current term expires at the Company’s 2022 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465922047904/0001104659-22-047904-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"requested not to be nominated"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c6322e4345","claim":"Mark Levin departed as Director at Voyager Therapeutics, Inc..","evidence_excerpt":"Mark Levin and Steven Paul, M.D. each requested not to be nominated for re-election to the Board when his current term expires at the Company’s 2022 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465922047904/0001104659-22-047904-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"requested not to be nominated"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}